These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19051373)

  • 1. Extensively drug-resistant tuberculosis.
    Cheruvu M; Bhadriraju S
    N Engl J Med; 2008 Nov; 359(22):2390-1; author reply 2391. PubMed ID: 19051373
    [No Abstract]   [Full Text] [Related]  

  • 2. Death of a health care worker with nosocomial extensively drug-resistant tuberculosis in India.
    James P; Christopher DJ; Balamugesh T; Gupta R
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):795-6. PubMed ID: 19460260
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with pulmonary resection for extensively drug-resistant tuberculosis.
    Shiraishi Y; Katsuragi N; Kita H; Toishi M; Onda T
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1075-8. PubMed ID: 18812334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistant tuberculosis: a growing public health threat.
    Salahuddin N
    J Coll Physicians Surg Pak; 2009 Sep; 19(9):537-8. PubMed ID: 19728935
    [No Abstract]   [Full Text] [Related]  

  • 5. Directly observed and standardized treatment in an era of extensively drug-resistant tuberculosis.
    Chang KC; Leung CC; Tam CM
    Clin Infect Dis; 2009 Jun; 48(11):1632-3; author reply 1633-4. PubMed ID: 19416026
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome of extensively drug-resistant tuberculosis.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):794; author reply 794-5. PubMed ID: 19460259
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facing extensively drug-resistant tuberculosis--a hope and a challenge.
    Raviglione MC
    N Engl J Med; 2008 Aug; 359(6):636-8. PubMed ID: 18687645
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.
    Migliori GB; Sotgiu G; D'Arcy Richardson M; Centis R; Guenther G; Hoffmann H; Cirillo DM; Toungossova O; Kliiman K; De Lorenzo S; Spanevello A; Lange C;
    Clin Infect Dis; 2009 Jul; 49(2):315-6; author reply 317. PubMed ID: 19538069
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment outcomes in extensively resistant tuberculosis.
    Chan ED; Strand MJ; Iseman MD
    N Engl J Med; 2008 Aug; 359(6):657-9. PubMed ID: 18687654
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effectiveness of screening for latent tuberculosis infection.
    Taylor Z
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S127-33. PubMed ID: 11144542
    [No Abstract]   [Full Text] [Related]  

  • 12. Extensively drug resistance (XDR) tb is not always fatal.
    Jain NK; Agnihotri SP; Sharma KK; Gupta S; Gupta P
    Indian J Tuberc; 2009 Jan; 56(1):48-50. PubMed ID: 19402272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of collapse therapy in pulmonary extensively drug-resistant tuberculosis].
    Haustraete E; Campbell K; Magnier R; Zalcman G; Bergot É
    Rev Pneumol Clin; 2014 Aug; 70(4):240-4. PubMed ID: 24210158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
    Schaaf HS; Willemse M; Donald PR
    Pediatr Infect Dis J; 2009 Aug; 28(8):748-50. PubMed ID: 19633523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panel discussion on MDR and XDR TB. Moderated by Dr. V.K. Arora.
    Arora VK; Singla R; Dhingra VK; Wares ; Prasad R; Selvakumar
    Indian J Tuberc; 2008 Apr; 55(2):104-9. PubMed ID: 18516829
    [No Abstract]   [Full Text] [Related]  

  • 16. Totally drug-resistant tuberculosis (TDR-TB) in India: every dark cloud has a silver lining.
    Udwadia Z; Vendoti D
    J Epidemiol Community Health; 2013 Jun; 67(6):471-2. PubMed ID: 23155059
    [No Abstract]   [Full Text] [Related]  

  • 17. XDR Tuberculosis: a report from the New Delhi Tuberculosis Centre, India.
    Dhingra VK; Malik S; Hanif M; Arora VK
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):133-5. PubMed ID: 19208323
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XDR tuberculosis can be cured with aggressive treatment.
    Cox H; McDermid C
    Lancet; 2008 Oct; 372(9647):1363-5. PubMed ID: 18723217
    [No Abstract]   [Full Text] [Related]  

  • 20. Extensively drug-resistant tuberculosis: back to the future.
    Migliori GB; Sotgiu G; Lange C; Centis R
    Eur Respir J; 2010 Sep; 36(3):475-7. PubMed ID: 20930199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.